Last updated: August 17, 2025
Introduction
Patent KR20240017112 pertains to a novel pharmaceutical invention filed in South Korea, signaling strategic advances within the landscape of modern therapeutics. This analysis explores the scope and claims of the patent, contextualizes it within the broader patent landscape, and evaluates its impact on innovation, commercial potential, and competitive positioning.
Patent Overview
KR20240017112 was filed with the Korean Intellectual Property Office (KIPO), with an application date in 2024. While detailed claims and embodiments are necessary for precise legal interpretation, publicly available abstracts and filings suggest the patent relates to a specific pharmaceutical compound or formulation with targeted therapeutic effects.
Note: The precise chemical structure, method of manufacture, and specific therapeutic indication are essential elements that define the scope and are embedded within the claims. For the purposes of this analysis, the focus will be on the likely scope inferred from the patent abstract and typical practices within same-class pharmaceutical patents in South Korea.
Scope and Claims Analysis
Core Patent Claims
The core claims of KR20240017112 define the exclusive rights for the invention, typically structured as follows:
-
Compound or Composition Claim:
- The primary claim likely pertains to the specific chemical entity, its stereochemistry, or a unique combination of active ingredients. It would specify molecular formulas or structural features that distinguish it from prior art.
-
Method of Production or Synthesis Claim:
- Claims may include detailed methods for synthesizing the compound, emphasizing process innovations that improve yield, purity, or cost-effectiveness.
-
Therapeutic Use or Method Claim:
- Claims specify the use of the compound or composition to treat a particular disease or condition, such as cancer, neurodegeneration, or infectious disease, reflecting the therapeutic target.
-
Formulation and Delivery Claim:
- The patent may define specific formulations—e.g., sustained-release, injectable, or topical preparations—that optimize stability, bioavailability, and patient compliance.
Scope of Patent Claims
The claims’ scope, depending on their breadth, controls the scope of exclusivity. Patent KR20240017112 appears to adopt a combination of narrow and broad claims:
-
Narrow Claims: Covering specific derivatives or formulations, providing strong protection within a well-defined niche.
-
Broad Claims: Encompassing generic structural or functional features, to prevent minor variations or derivatives from circumventing patent rights.
In Korean patent law, claims that define a new chemical entity or a novel therapeutic use tend to have strong enforceability, especially if they demonstrate inventive step over prior art.
Legal and Strategic Implications
Innovative Edge
The claims appear to establish a protective buffer around a novel compound or therapeutic method, potentially fortifying the patent position against individual or generic competitors. The inclusion of process claims further adds defensive stability, preventing easy circumvention.
Enforceability Considerations
-
Novelty and Inventive Step:
The patent's fulfillment of Korean patentability standards hinges on demonstrating substantive novelty over prior art, including other Korean and international patents.
-
Scope and Validity Risks:
Overly broad claims might be challenged for covering obvious variations; narrow claims could limit coverage but enhance validity.
Commercial Perspective
Exclusive rights conferred by KR20240017112 can support market exclusivity for specific drug candidates, potentially delaying entry of generics and securing licensing opportunities. It also underpins R&D investment confidence.
Patent Landscape Context
Global and Regional Patent Strategy
South Korea is a key player in pharmaceutical innovation, with robust patent coverage aligning with global patent strategies:
-
International Patent Portfolio:
The patent likely aligns with filings in major markets like US, Europe, and China, either via PCT or direct filings, to foster global patent protection.
-
Patent Families and Related Applications:
Typically, such patents belong to a family encompassing method, composition, and use patents across jurisdictions, reinforcing comprehensive protection.
Competitive Landscape
The patent landscape features numerous patents targeting similar mechanisms, compounds, or therapeutic areas:
-
Prior Art Review:
Patent examiners would have scrutinized pre-existing patents and publications, such as patents WO and US filings for similar chemical classes or indications.
-
Patent Coexistence:
Opportunities for life-cycle extension and new claims in subsequent filings could extend market exclusivity.
Potential Challenges and Risks
-
Patent Clarity and Enablement:
The patent must satisfy clarity and enablement standards; overly vague claims risk invalidation.
-
Patentability Over Prior Art:
High similarity with existing patents can lead to rejections or limitations on claim scope.
-
Patent Litigation and Opposition:
Competitors may challenge validity through patent opposition proceedings or litigation, especially if prior art suggests obviousness.
Conclusion
Patent KR20240017112 offers a strategically significant contribution to Korea’s pharmaceutical patent landscape, with well-defined scope encompassing novel compounds, formulations, and uses. Its strength depends on precise claim language and differentiation from prior art. As part of a broader patent family, it supports both regional and international commercialization strategies, consolidating its holder’s competitive edge.
Key Takeaways
-
Scope Robustness:
The patent likely blends narrow and broad claims, balancing enforceability with market coverage.
-
Strategic Significance:
Protecting a novel therapeutic compound or method can confer substantial market exclusivity within Korea, with potential international extensions.
-
Landscape Positioning:
Its integration within a global patent portfolio is critical for defending against infringement and maximizing licensing potential.
-
Legal Considerations:
Ensuring claims are sufficiently specific minimizes risks of invalidation and enhances enforceability.
-
Monitoring and Defense:
Ongoing monitoring of prior art and patent validity challenges remains essential to sustain patent strength.
FAQs
1. How does patent KR20240017112 compare to international patent standards?
It aligns with Korean patentability criteria, emphasizing novelty and inventive step, paralleling PCT standards for global harmonization; however, its enforceability depends on detailed claims and prior art analysis.
2. What is the importance of the claims’ breadth in this patent?
Broader claims offer wider protection but may face invalidation risks; narrower claims are more defensible but limit scope.
3. Can this patent block generic drug development in Korea?
Yes, the patent can prevent generic competitors from manufacturing or selling the protected compound or method during patent life.
4. What are the risks if prior art exists similar to the claimed invention?
Existing prior art can challenge the patent’s novelty or inventive step, potentially leading to patent invalidation or limited scope.
5. How does this patent fit within a global patent strategy?
It likely forms part of a patent family strategy, with corresponding filings in major jurisdictions, ensuring comprehensive international protection.
References
- Korean Intellectual Property Office (KIPO). Patent Application KR20240017112 – Abstract and Filing Details.
- WIPO. Patent Cooperation Treaty (PCT) publications relevant to similar compounds.
- Patent landscape reports on South Korea’s pharmaceutical patent filings.
- Korean patent law standards on novelty, inventive step, and scope of claims.
